Combined intravenous immunoglobulin and methylprednisolone as induction treatment in chronic inflammatory demyelinating polyneuropathy (OPTIC protocol): a prospective pilot study-Reference-Cited by-同舟云学术

Combined intravenous immunoglobulin and methylprednisolone as induction treatment in chronic inflammatory demyelinating polyneuropathy (OPTIC protocol): a prospective pilot study

Published:2019-11-07 Issue:3 Volume:27 Page:506-513
ISSN:1351-5101
Container-title:European Journal of Neurology
language:en
Short-container-title:Eur J Neurol

Author:

Adrichem M. E.¹^ORCID,Bus S. R.¹,Wieske L.¹,Mohammed H.²,Verhamme C.¹,Hadden R.²,Schaik I. N.¹,Eftimov F.¹

Affiliation:

1. Department of Neurology Amsterdam Neuroscience Amsterdam UMC University of Amsterdam Amsterdam the Netherlands

2. Department of Neurology Maidstone Hospital Maidstone Kent UK

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ene.14096

Reference17 articles.

1. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripher

2. Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial

3. Pulsed high-dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double-blind, randomised, controlled trial

4. Timing and Course of Clinical Response to Intravenous Immunoglobulin in Chronic Inflammatory Demyelinating Polyradiculoneuropathy

5. Long-term remission of CIDP after pulsed dexamethasone or short-term prednisolone treatment

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review of steroid use in peripheral nerve pathologies and treatment;Frontiers in Neurology;2024-09-02

2. Polirradiculoneuritis adquiridas agudas y crónicas en la infancia;EMC - Pediatría;2024-03

3. Serum B-cell activating factor is not a potential biomarker for disease activity in chronic inflammatory demyelinating polyneuropathy;Journal of Neuroimmunology;2023-09

4. B‐cell and T‐cell receptor repertoire in chronic inflammatory demyelinating polyneuropathy, a prospective cohort study;Journal of the Peripheral Nervous System;2023-02-14

5. On the path to evidence-based therapy in neuromuscular disorders;Motor System Disorders, Part I: Normal Physiology and Function and Neuromuscular Disorders;2023